The microbiome in pediatric cystic fibrosis patients: The role of shared environment suggests a window of intervention

Microbiome

Volumn 2, Issue 1, 2014, Pages

  Hampton, Thomas H ^a   Green, Deanna M ^b   Cutting, Garry R ^c   Morrison, Hilary G ^d   Sogin, Mitchell L ^d   Gifford, Alex H ^a   Stanton, Bruce A ^a   O'Toole, George A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MARINE BIOLOGICAL LABORATORY   (United States)

Author keywords

Cystic fibrosis; Microbiome; Pseudomonas aeruginosa; Sputum

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DIZYGOTIC TWINS; ENVIRONMENT; HUMAN; MICROBIAL DIVERSITY; MICROBIOME; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIBLING; SPUTUM; SPUTUM ANALYSIS; STREPTOCOCCUS;

BACTERIA (MICROORGANISMS); PSEUDOMONAS AERUGINOSA;

EID: 84924981899     PISSN: None     EISSN: 20492618     Source Type: Journal    
DOI: 10.1186/2049-2618-2-14     Document Type: Article

References (24)

1. Chmiel JF, Davis PB. State of the art: Why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?. Respir Res 2003, 4:8. 10.1186/1465-9921-4-8, 203156, 14511398.
2. Salvatore D, Buzzetti R, Baldo E, Furnari ML, Lucidi V, Manunza D, Marinelli I, Messore B, Neri AS, Raia V, Mastella G. An overview of international literature from cystic fibrosis registries. Part 4: Update 2011. J Cyst Fibros 2012, 11:480-493. 10.1016/j.jcf.2012.07.005, 22884375.
3. Hurley MN, Ariff AH, Bertenshaw C, Bhatt J, Smyth AR. Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis. J Cyst Fibros 2012, 11:288-292. 10.1016/j.jcf.2012.02.006, 3382712, 22436723.
4. Lynch SV, Bruce KD. The cystic fibrosis airway microbiome. Cold Spring Harb Perspect Med 2013, 3:a009738.
5. Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, Wu B, Tran D, Koff J, Kleinhenz ME, Nielson D, Brodie EL, Lynch SV. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 2010, 5:e11044. 10.1371/journal.pone.0011044, 2890402, 20585638.
6. Madan JC, Koestler DC, Stanton BA, Davidson L, Moulton LA, Housman ML, Moore JH, Guill MF, Morrison HG, Sogin ML, Hampton TH, Karagas MR, Palumbo PE, Foster JA, Hibberd PL, O'Toole GA. Serial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposures. MBio 2012, 3:e00251-12.
7. Goddard AF, Staudinger BJ, Dowd SE, Joshi-Datar A, Wolcott RD, Aitken ML, Fligner CL, Singh PK. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc Natl Acad Sci U S A 2012, 109:13769-13774. 10.1073/pnas.1107435109, 3427132, 22872870.
8. Collaco JM, Blackman SM, McGready J, Naughton KM, Cutting GR. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr 2010, 157:802-807. e1-e3, 10.1016/j.jpeds.2010.05.018, 2948620, 20580019.
9. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002, 34:91-100. 10.1002/ppul.10127, 12112774.
10. Nixon GM, Armstrong DS, Carzino R, Carlin JB, Olinsky A, Robertson CF, Grimwood K. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001, 138:699-704. 10.1067/mpd.2001.112897, 11343046.
11. Kosorok MR, Zeng L, West SE, Rock MJ, Splaingard ML, Laxova A, Green CG, Collins J, Farrell PM. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001, 32:277-287. 10.1002/ppul.2009.abs, 11568988.
12. Green DM, Collaco JM, McDougal KE, Naughton KM, Blackman SM, Cutting GR. Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis. J Pediatr 2012, 161:290-295. e1, 10.1016/j.jpeds.2012.01.042, 3682831, 22364820.
13. Gifford AH, Alexandru DM, Li Z, Dorman DB, Moulton LA, Price KE, Hampton TH, Sogin ML, Zuckerman JB, Parker HW, Stanton BA, O'Toole GA. Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis. J Cyst Fibros 2014, 13:311-318. 10.1016/j.jcf.2013.11.004, 24332997.
14. Henig NR, Tonelli MR, Pier MV, Burns JL, Aitken ML. Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis. Thorax 2001, 56:306-311. 10.1136/thorax.56.4.306, 1746031, 11254823.
15. Price KE, Hampton TH, Gifford AH, Dolben EL, Hogan DA, Morrison HG, Sogin ML, O'Toole GA. Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation. Microbiome 2013, 1:27. 10.1186/2049-2618-1-27, 3971630, 24451123.
16. Goslee SC, Urban DL. The ecodist package for dissimilarity-based analysis of ecological data. J Stat Softw 2007, 22(7):1-19.
17. Dixon P. VEGAN, a package of R functions for community ecology. J Veg Sci 2003, 14:927-930.
18. Huse SM, Welch DBM, Voorhis A, Shipunova A, Morrison HG, Eren AM, Sogin ML. VAMPS: a website for visualization and analysis of microbial population structures. BMC Bioinformatics 2014, 15:41. 10.1186/1471-2105-15-41, 3922339, 24499292.
19. Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med 2013, 187:1118-1126. 10.1164/rccm.201210-1937OC, 23348972.
20. Zhao J, Schloss PD, Kalikin LM, Carmody LA, Foster BK, Petrosino JF, Cavalcoli JD, VanDevanter DR, Murray S, Li JZ, Young VB, LiPuma JJ. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A 2012, 109:5809-5814. 10.1073/pnas.1120577109, 3326496, 22451929.
21. Klepac-Ceraj V, Lemon KP, Martin TR, Allgaier M, Kembel SW, Knapp AA, Lory S, Brodie EL, Lynch SV, Bohannan BJ, Green JL, Maurer BA, Kolter R. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 2010, 12:1293-1303. 10.1111/j.1462-2920.2010.02173.x, 20192960.
22. Psoter KJ, De Roos AJ, Wakefield J, Mayer J, Rosenfeld M. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect 2013, 19:E483-E489.
23. Blainey PC, Milla CE, Cornfield DN, Quake SR. Quantitative analysis of the human airway microbial ecology reveals a pervasive signature for cystic fibrosis. Sci Transl Med 2012, 4:153ra130. 3898170, 23019655.
24. Stressmann FA, Rogers GB, van der Gast CJ, Marsh P, Vermeer LS, Carroll MP, Hoffman L, Daniels TW, Patel N, Forbes B, Bruce KD. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience. Thorax 2012, 67:867-873. 10.1136/thoraxjnl-2011-200932, 22707521.